JOHNSON & JOHNSON Current Assets 2008-2026 | JNJ
Beta
What is current assets?
Current assets are resources expected to be converted to cash or consumed within one year or the normal operating cycle of the business.
What is JOHNSON & JOHNSON's current current assets?
JOHNSON & JOHNSON (JNJ) annual current assets for 2025 was $55.62B, a 0.48% decline from 2024. JOHNSON & JOHNSON current assets for the quarter ending March 29, 2026 was $59.17B.
What was JOHNSON & JOHNSON's current assets in 2024?
JOHNSON & JOHNSON annual current assets for 2024 was $55.89B, a 4.48% increase from 2023.
What was JOHNSON & JOHNSON's current assets in 2023?
JOHNSON & JOHNSON annual current assets for 2023 was $53.49B, a 12.27% decline from 2022.
What is JOHNSON & JOHNSON's 4-year current assets CAGR?
JOHNSON & JOHNSON current assets grew at a compound annual growth rate (CAGR) of 2.08% from FY2021 to FY2025, going from $51.24B to $55.62B over 4 years.
Current Assets History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+4.2%
FY2019
$45.27B
→
FY2025
$55.62B
081011121314161718192122232425
5 years selected
Current Assets History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $55.62B | -0.5% | 10-K |
| FY2024 | $55.89B | +4.5% | 10-K |
| FY2023 | $53.49B | -12.3% | 10-K |
| FY2022 | $60.98B | +19.0% | 10-K |
| FY2021 | $51.24B | +13.2% | 10-K |
| FY2019 | $45.27B | -1.6% | 10-K |
| FY2018 | $46.03B | +6.8% | 10-K |
| FY2017 | $43.09B | -28.4% | 10-K |
| FY2016 | $60.21B | +8.0% | 10-K |
| FY2014 | $55.74B | -1.2% | 10-K |
| FY2013 | $56.41B | +22.3% | 10-K |
| FY2012 | $46.12B | -2.5% | 10-K |
| FY2011 | $47.31B | +19.6% | 10-K |
| FY2010 | $39.54B | +15.0% | 10-K |
| FY2008 | $34.38B | - | 10-K |
Company: JOHNSON & JOHNSONTicker: JNJSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →